GROWTH / DIRECT CATALOG PRICING
HGH 191aa
HGH 191aa denotes somatropin, recombinant human growth hormone comprising 191 amino acids. FDA labeling describes approved somatropin products as sequence-identical to the dominant pituitary human growth-hormone form.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Growth
- 10 IUPricing by inquiry · AvailableSelect
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
HGH 191aa denotes somatropin, recombinant human growth hormone comprising 191 amino acids. FDA labeling describes approved somatropin products as sequence-identical to the dominant pituitary human growth-hormone form.
The growth classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Growth
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
HGH 191aa denotes somatropin, recombinant human growth hormone comprising 191 amino acids. FDA labeling describes approved somatropin products as sequence-identical to the dominant pituitary human growth-hormone form.
- Research covered
- FDA product labeling establishes the 191-amino-acid recombinant protein identity and describes approved, manufacturer-specific formulations. It does not evaluate or authenticate generic catalog material sold under the shorthand HGH 191aa.
- Important limit
- The catalog does not identify a licensed manufacturer, expression system, mass-per-IU relationship, excipients, or analytical release data. An FDA label for an approved product cannot be transferred to an unverified vendor vial.
- Authoritative sources
FACTUAL FAQ
HGH 191aa catalog questions
What formats are currently listed?
10 IU. Current price and stock state appear above.
What did researchers study?
FDA product labeling establishes the 191-amino-acid recombinant protein identity and describes approved, manufacturer-specific formulations. It does not evaluate or authenticate generic catalog material sold under the shorthand HGH 191aa.
What is the most important evidence limit?
The catalog does not identify a licensed manufacturer, expression system, mass-per-IU relationship, excipients, or analytical release data. An FDA label for an approved product cannot be transferred to an unverified vendor vial.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
